Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9

Citation
Mj. Scanlan et al., Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9, CANCER LETT, 150(2), 2000, pp. 155-164
Citations number
30
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
150
Issue
2
Year of publication
2000
Pages
155 - 164
Database
ISI
SICI code
0304-3835(20000331)150:2<155:EOCAIL>2.0.ZU;2-7
Abstract
In an effort to define new cancer-testis (CT) genes, we investigated whethe r BRDT, a testis-restricted member of the RING3 family of transcriptional r egulators, is also expressed in cancer. Standard RT-PCR expression analysis detected BRDT transcripts in 12 of 47 cases of non-small cell lung cancer and single cases of both squamous cell carcinoma of the head and neck (1/12 ) and esophagus (1/12) but not in melanoma or in cancers of the colon, brea st, kidney and bladder. Typing of 33 non-small cell lung cancers for coexpr ession of a panel of CT antigens revealed a high incidence (60%) of MAGE-3 mRNA expression, followed by MAGE-1 (36%), CT7/MAGE-C1 (30%), CT10 (30%), S SX4 (23%), BRDT (21%), NY-ESO-1 (21%) and HOM-MEL-40/SSX2 (15%). The coexpr ession pattern of these antigens provides a foundation for developing a pol yvalent lung cancer vaccine. (C) 2000 Elsevier Science Ireland Ltd. All rig hts reserved.